Naftzger J. Christopher

General Counsel and CCO at Arbutus Biopharma Corp · on record since Jul 12, 2023
See Remarks at Unilife Corp · on record since Jul 8, 2010
General Counsel and Corp Sec at Nabriva Therapeutics plc · on record since Sep 15, 2021

Insider trading activity of Naftzger J. Christopher

Transactions on record: 22; since Jul 8, 2010

Open-market buys: 3; $26.2K

Open-market sells: 1; $37.2K

Companies traded: 3; last filing Feb 19, 2025

Figures computed from official regulatory filings — .

Companies where Naftzger J. Christopher has traded

Arbutus Biopharma Corp6 tx · $37.2K · Feb 19, 2025
Nabriva Therapeutics plc8 tx · $4.1K · Aug 15, 2022
Unilife Corp8 tx · $36.2K · May 30, 2013

Track record of Naftzger J. Christopher

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Naftzger J. Christopher

Co-insiders of Naftzger J. Christopher

BURGESS DANIEL DArbutus Biopharma Corp +1
HASTINGS DAVID CArbutus Biopharma Corp +1
Abrams Michael J.Arbutus Biopharma Corp
Allan StephenUnilife Corp
AMGEN INCUnilife Corp
Androski LindsayArbutus Biopharma Corp
Beardsley Robert AArbutus Biopharma Corp
Bishop Joseph EArbutus Biopharma Corp
Bolte AxelNabriva Therapeutics plc
Bosnjak JimUnilife Corp
Bourdow Carrie L.Nabriva Therapeutics plc
Brennan Paul A.Arbutus Biopharma Corp
Broom Colin MDNabriva Therapeutics plc
Calvert DanielUnilife Corp
Carter JeffUnilife Corp
Cheng AndrewArbutus Biopharma Corp
Collier William H.Arbutus Biopharma Corp

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Arbutus Biopharma CorpListing on record	Feb 19, 2025	Award	54,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 19, 2025	AwardD (derivative)	220,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2025	Sell	-11,333	3.28 USD	$37.2K		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2024	Award	95,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2024	AwardD (derivative)	380,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Jul 12, 2023	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	-31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	-63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Feb 1, 2022	AwardD (derivative)	31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Feb 1, 2022	AwardD (derivative)	63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Dec 28, 2021	Buy	7,000	0.59 USD	$4.1K	conv 72First in 12mo	SEC
Nabriva Therapeutics plcListing unverified	Oct 1, 2021	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	May 30, 2013	Award	165,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Mar 22, 2012	Award	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Nov 22, 2011	Buy	2,000	3.96 USD	$7.9K	conv 45Cluster	SEC
Unilife CorpListing unverified	Nov 14, 2011	Other	-3,060	4.62 USD	$14.1K		SEC
Unilife CorpListing unverified	Mar 2, 2011	Buy	3,000	4.70 USD	$14.1K	conv 43First in 12mo	SEC
Unilife CorpListing unverified	Jan 5, 2011	AwardD (derivative)	12,821	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Jul 8, 2010	AwardD (derivative)	60,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Jul 8, 2010	Award	40,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Arbutus Biopharma CorpListing on record	Feb 19, 2025	Award	54,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 19, 2025	AwardD (derivative)	220,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2025	Sell	-11,333	3.28 USD	$37.2K		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2024	Award	95,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Feb 5, 2024	AwardD (derivative)	380,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Arbutus Biopharma CorpListing on record	Jul 12, 2023	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	-31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	-63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Aug 15, 2022	ExerciseD (derivative)	63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Feb 1, 2022	AwardD (derivative)	31,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Feb 1, 2022	AwardD (derivative)	63,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nabriva Therapeutics plcListing unverified	Dec 28, 2021	Buy	7,000	0.59 USD	$4.1K	conv 72First in 12mo	SEC
Nabriva Therapeutics plcListing unverified	Oct 1, 2021	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	May 30, 2013	Award	165,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Mar 22, 2012	Award	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Nov 22, 2011	Buy	2,000	3.96 USD	$7.9K	conv 45Cluster	SEC
Unilife CorpListing unverified	Nov 14, 2011	Other	-3,060	4.62 USD	$14.1K		SEC
Unilife CorpListing unverified	Mar 2, 2011	Buy	3,000	4.70 USD	$14.1K	conv 43First in 12mo	SEC
Unilife CorpListing unverified	Jan 5, 2011	AwardD (derivative)	12,821	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Jul 8, 2010	AwardD (derivative)	60,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Unilife CorpListing unverified	Jul 8, 2010	Award	40,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC